Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

C4b-Binding Protein Deposition is Induced in Diseased Aortic Heart Valves, Coinciding with C3d

Dikhoff, Marie Jose ; ter Weeme, Mimi ; Vonk, Alexander B. A. ; Kupreishvili, Koba ; Blom, Anna LU orcid ; Krijnen, Paul A. J. ; Stooker, Wim and Niessen, Hans W. M. (2015) In Journal of Heart Valve Disease 24(4). p.451-456
Abstract
Background and aim of the study: It has been found recently that activated complement is more widespread in diseased aortic valves compared to the endogenous complement inhibitors C1-inhibitor and clusterin. Previously, another endogenous inhibitor of complement, C4b-binding protein (C4BP) has been described in atherosclerotic diseased coronary arteries. The study aim was to analyze C4BP levels in diseased aortic valves. Methods: Aortic valve tissue was derived from surgical procedures and classified as 'degenerative', 'atherosclerotic' or 'atherosclerotic with bacterial infection'. Valves were stained with specific antibodies against C4BP, C3d and caspase-3. Areas of positivity were then quantified using computer assisted morphometry.... (More)
Background and aim of the study: It has been found recently that activated complement is more widespread in diseased aortic valves compared to the endogenous complement inhibitors C1-inhibitor and clusterin. Previously, another endogenous inhibitor of complement, C4b-binding protein (C4BP) has been described in atherosclerotic diseased coronary arteries. The study aim was to analyze C4BP levels in diseased aortic valves. Methods: Aortic valve tissue was derived from surgical procedures and classified as 'degenerative', 'atherosclerotic' or 'atherosclerotic with bacterial infection'. Valves were stained with specific antibodies against C4BP, C3d and caspase-3. Areas of positivity were then quantified using computer assisted morphometry. Results: In atherosclerotic valves, the areas of C4BP and C3d positivity (38.8 +/- 0.4% versus 32.7 +/- 1.0%, respectively) were significantly higher compared to the degenerative and control groups. In atherosclerotic valves with bacterial infection, the area of positivity for C4BP was even further increased compared to atherosclerotic valves (65.1 +/- 1.2%; 70.1 +/- 1.9% for C3d). The areas of C4BP and C3d positivity were not significantly different in all groups. Caspase-3 was only present in <10% of endothelial cells in the atherosclerotic valves without bacterial infection and in neutrophilic granulocytes in atherosclerotic valves, with and without bacterial infection. Conclusion: It has been shown for the first time that C4BP is deposited in the diseased aortic valve, coinciding with C3d. The area of C4BP positivity was more extensive compared to the areas of other endogenous complement inhibitors (C1-inhibitor and clusterin). (Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Journal of Heart Valve Disease
volume
24
issue
4
pages
451 - 456
publisher
ICR Publishers
external identifiers
  • wos:000369045700009
  • scopus:85005765143
ISSN
0966-8519
language
English
LU publication?
yes
id
48e5faa9-96af-4fb3-bd52-9de812912166 (old id 8731778)
date added to LUP
2016-04-01 13:12:28
date last changed
2022-01-27 17:56:32
@article{48e5faa9-96af-4fb3-bd52-9de812912166,
  abstract     = {{Background and aim of the study: It has been found recently that activated complement is more widespread in diseased aortic valves compared to the endogenous complement inhibitors C1-inhibitor and clusterin. Previously, another endogenous inhibitor of complement, C4b-binding protein (C4BP) has been described in atherosclerotic diseased coronary arteries. The study aim was to analyze C4BP levels in diseased aortic valves. Methods: Aortic valve tissue was derived from surgical procedures and classified as 'degenerative', 'atherosclerotic' or 'atherosclerotic with bacterial infection'. Valves were stained with specific antibodies against C4BP, C3d and caspase-3. Areas of positivity were then quantified using computer assisted morphometry. Results: In atherosclerotic valves, the areas of C4BP and C3d positivity (38.8 +/- 0.4% versus 32.7 +/- 1.0%, respectively) were significantly higher compared to the degenerative and control groups. In atherosclerotic valves with bacterial infection, the area of positivity for C4BP was even further increased compared to atherosclerotic valves (65.1 +/- 1.2%; 70.1 +/- 1.9% for C3d). The areas of C4BP and C3d positivity were not significantly different in all groups. Caspase-3 was only present in &lt;10% of endothelial cells in the atherosclerotic valves without bacterial infection and in neutrophilic granulocytes in atherosclerotic valves, with and without bacterial infection. Conclusion: It has been shown for the first time that C4BP is deposited in the diseased aortic valve, coinciding with C3d. The area of C4BP positivity was more extensive compared to the areas of other endogenous complement inhibitors (C1-inhibitor and clusterin).}},
  author       = {{Dikhoff, Marie Jose and ter Weeme, Mimi and Vonk, Alexander B. A. and Kupreishvili, Koba and Blom, Anna and Krijnen, Paul A. J. and Stooker, Wim and Niessen, Hans W. M.}},
  issn         = {{0966-8519}},
  language     = {{eng}},
  number       = {{4}},
  pages        = {{451--456}},
  publisher    = {{ICR Publishers}},
  series       = {{Journal of Heart Valve Disease}},
  title        = {{C4b-Binding Protein Deposition is Induced in Diseased Aortic Heart Valves, Coinciding with C3d}},
  volume       = {{24}},
  year         = {{2015}},
}